Literature DB >> 15016335

Complement as a source of biomarkers in systemic lupus erythematosus: past, present, and future.

Chau-Ching Liu1, Joseph M Ahearn, Susan Manzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15016335     DOI： 10.1007/s11926-004-0046-8

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


× No keyword cloud information.
  17 in total

1.  The response of serum gamma globulin level and complement titer to adrenocorticotropic hormone therapy in lupus erythematosus disseminatus.

Authors:  J H VAUGHAN; T B BAYLES; C B FAVOUR
Journal:  J Lab Clin Med       Date:  1951-05

2.  Immunologic factors and clinical activity in systemic lupus erythematosus.

Authors:  P H Schur; J Sandson
Journal:  N Engl J Med       Date:  1968-03-07       Impact factor: 91.245

Review 3.  Origin of the fourth component of complement related Chido and Rodgers blood group antigens.

Authors:  J P Atkinson; A C Chan; D R Karp; C C Killion; R Brown; D Spinella; D C Shreffler; R P Levine
Journal:  Complement       Date:  1988

4.  Localisation of Chido and Rodgers determinants to the C4d fragment of human C4.

Authors:  C A Tilley; D G Romans; M C Crookston
Journal:  Nature       Date:  1978-12-14       Impact factor: 49.962

5.  Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study.

Authors:  E J ter Borg; G Horst; E J Hummel; P C Limburg; C G Kallenberg
Journal:  Arthritis Rheum       Date:  1990-05

6.  Serologically active clinically quiescent systemic lupus erythematosus--predictors of clinical flares.

Authors:  B A Walz LeBlanc; D D Gladman; M B Urowitz
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

7.  Radioimmunoassay of the attack complex of complement in serum from patients with systemic lupus erythematosus.

Authors:  R J Falk; A P Dalmasso; Y Kim; S Lam; A Michael
Journal:  N Engl J Med       Date:  1985-06-20       Impact factor: 91.245

8.  Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail.

Authors:  J M Esdaile; M Abrahamowicz; L Joseph; T MacKenzie; Y Li; D Danoff
Journal:  Arthritis Rheum       Date:  1996-03

9.  Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE).

Authors:  W Lloyd; P H Schur
Journal:  Medicine (Baltimore)       Date:  1981-05       Impact factor: 1.889

10.  Serum C3 levels are diagnostically more sensitive and specific for systemic lupus erythematosus activity than are serum C4 levels. The Lupus Nephritis Collaborative Study Group.

Authors:  D M Ricker; L A Hebert; R Rohde; D D Sedmak; E J Lewis; J D Clough
Journal:  Am J Kidney Dis       Date:  1991-12       Impact factor: 8.860
View more
  10 in total

1.  Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus.

Authors:  Amy H Kao; Jeannine S Navratil; Margie J Ruffing; Chau-Ching Liu; Douglas Hawkins; Kathleen M McKinnon; Natalya Danchenko; Joseph M Ahearn; Susan Manzi
Journal:  Arthritis Rheum       Date:  2010-03

Review 2.  Diagnostic and prognostic tests in systemic lupus erythematosus.

Authors:  Natalia Vasquez-Canizares; Dawn Wahezi; Chaim Putterman
Journal:  Best Pract Res Clin Rheumatol       Date:  2017-11-06       Impact factor: 4.098

3.  Cell-bound complement biomarkers for systemic lupus erythematosus: from benchtop to bedside.

Authors:  Chau-Ching Liu; Susan Manzi; Amy H Kao; Jeannine S Navratil; Joseph M Ahearn
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

Review 4.  The search for lupus biomarkers.

Authors:  Chau-Ching Liu; Joseph M Ahearn
Journal:  Best Pract Res Clin Rheumatol       Date:  2009-08       Impact factor: 4.098

5.  Lymphocyte-bound complement activation products as biomarkers for diagnosis of systemic lupus erythematosus.

Authors:  Chau-Ching Liu; Amy H Kao; Douglas M Hawkins; Susan Manzi; Abdus Sattar; Nicole Wilson; Joseph M Ahearn
Journal:  Clin Transl Sci       Date:  2009-08       Impact factor: 4.689

Review 6.  New advances in measurement of complement activation: lessons of systemic lupus erythematosus.

Authors:  Chau-Ching Liu; Susan Manzi; Natalya Danchenko; Joseph M Ahearn
Journal:  Curr Rheumatol Rep       Date:  2004-10       Impact factor: 4.592

7.  Cell-bound complement activation products in systemic lupus erythematosus: comparison with anti-double-stranded DNA and standard complement measurements.

Authors:  Chaim Putterman; Richard Furie; Rosalind Ramsey-Goldman; Anca Askanase; Jill Buyon; Kenneth Kalunian; W Winn Chatham; Elena Massarotti; Kyriakos Kirou; Nicole Jordan; Irene Blanco; Arthur Weinstein; Puja Chitkara; Susan Manzi; Joseph Ahearn; Tyler O'Malley; John Conklin; Claudia Ibarra; Derren Barken; Thierry Dervieux
Journal:  Lupus Sci Med       Date:  2014-10-01

8.  Systemic lupus erythematosus and primary fibromyalgia can be distinguished by testing for cell-bound complement activation products.

Authors:  Daniel J Wallace; Stuart L Silverman; John Conklin; Derren Barken; Thierry Dervieux
Journal:  Lupus Sci Med       Date:  2016-02-01

9.  The spectrum of renal thrombotic microangiopathy in lupus nephritis.

Authors:  Di Song; Li-hua Wu; Feng-mei Wang; Xiao-wei Yang; Di Zhu; Min Chen; Feng Yu; Gang Liu; Ming-hui Zhao
Journal:  Arthritis Res Ther       Date:  2013-01-15       Impact factor: 5.156

10.  Neutrophil to Lymphocyte Ratio and Mean Platelet Volume as Inflammatory Indicators in Systemic Lupus Erythematosus Nephritis.

Authors:  Ata Bora Ayna; Selime Ermurat; Belkis Nihan Coşkun; Halil Harman; Yavuz Pehlivan
Journal:  Arch Rheumatol       Date:  2016-08-17       Impact factor: 1.472
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.